MOLECULAR CHARACTERIZATION OF MUSCARINIC ACH RECEPTORS
毒蕈碱 ACH 受体的分子表征
基本信息
- 批准号:3402164
- 负责人:
- 金额:$ 10.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-23 至 1988-08-31
- 项目状态:已结题
- 来源:
- 关键词:acetylcholine affinity chromatography autoradiography chemical binding electron microscopy gel electrophoresis genetic library genetic translation histochemistry /cytochemistry hybridomas immunochemistry ligands molecular weight monoclonal antibody neural information processing neurochemistry synapses
项目摘要
The long-range goal of this work is to understand how signal transduction
is established and maintained at CNS cholinergic synapses; its focus is on
the biochemistry, development and cellular regulation of muscarinic ACh
receptors. These receptors mediate a large proportion of CNS cholinergic
signaling, have been implicated in many behaviorally and clinically
significant phenomena and show a broad spectrum of transductional and
regulatory responses. At present, it appears most appropriate to isolate
and begin characterizing receptor system proteins and to generate receptor
specific antibodies for studies of muscarinic cell and developmental
biology. The following three aims have therefore been chosen:
AIM #1--To generate a library of muscarinic receptor-specific monoclonal
antibodies. Partially purified (250-fold) bovine brain receptors will be
used for antibody induction using a combination of methods already tested
for their effectiveness. Binding assays and western blots will be used in
testing antibody specificity.
AIM #2--To purify and begin characterization of receptor molecules.
Immunoaffinity chromatography will be added to tested separations based on
subcellular fractionation, hydrophobicity, charge, molecular weight and
specific glycosylation. 2D-Gel, sedimentation equilibrium and N-terminal
analyses will be used in testing purity. The ligand specificity, number of
subunits, number of binding sites, and overall amino acid composition of
the purified molecules will be assessed.
AIM #3--To localize receptors as a function of synaptic development,
post-translational modification, and cholinergic stimulation. The
monoclonal antibodies obtained above will be used to localize receptors on
avian retina neurons at the subcellular and ultrastructural levels. A
novel approach employing isolation of differentiated neurons and HVEM whole
mount analysis will be used.
这项工作的长期目标是了解信号转导是如何
在中枢神经系统胆碱能突触建立和维持;其重点是
毒扁豆碱酸乙酰胆碱的生化、发育及细胞调控
感受器。这些受体介导了很大比例的中枢胆碱能
信号转导,在许多行为和临床上都有牵连
显著的现象,并显示出广泛的换能器和
监管回应。目前看来,分离最合适的方法是
并开始鉴定受体系统蛋白质并产生受体
M细胞和发育研究中的特异性抗体
生物学。因此,我们选择了以下三个目标:
目的#1--构建M受体特异性单抗文库
抗体。部分纯化(250倍)的牛脑受体将被
用于使用已经测试的多种方法的组合来诱导抗体
因为他们的有效性。结合分析和免疫印迹将用于
检测抗体的特异性。
目的#2--提纯并开始鉴定受体分子。
免疫亲和层析将添加到测试的分离中,基于
亚细胞分级、疏水性、电荷、相对分子质量和
特定的糖基化。二维凝胶、沉淀平衡和N-末端
分析将用于检测纯度。配基的特异性、数量
亚基、结合位点数和总的氨基酸组成
将对纯化的分子进行评估。
目标#3--定位受体作为突触发育的功能,
翻译后修饰和胆碱能刺激。这个
以上获得的单抗将用于定位受体。
亚细胞和超微结构水平的鸟类视网膜神经元。一个
一种新的分离分化神经元和HVEM整体的方法
将使用装载分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM L KLEIN其他文献
WILLIAM L KLEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM L KLEIN', 18)}}的其他基金
Physiological role of naturally-occuring amyloid beta oligomers
天然存在的β淀粉样蛋白寡聚体的生理作用
- 批准号:
9759747 - 财政年份:2018
- 资助金额:
$ 10.12万 - 项目类别:
Development of a non-fibrillic amyloid-beta oligomer selective positron emission tomography imaging diagnostic for Alzheimer.
开发用于阿尔茨海默氏症的非纤维状淀粉样蛋白-β寡聚物选择性正电子发射断层扫描成像诊断。
- 批准号:
9202960 - 财政年份:2016
- 资助金额:
$ 10.12万 - 项目类别:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
一种用于早期阿尔茨海默病诊断的新型纳米粒子分子 MRI 探针
- 批准号:
8842908 - 财政年份:2014
- 资助金额:
$ 10.12万 - 项目类别:
A novel, nanoparticle-based molecular MRI probe for early Alzheimer's diagnostics
一种用于早期阿尔茨海默病诊断的新型纳米粒子分子 MRI 探针
- 批准号:
8683797 - 财政年份:2014
- 资助金额:
$ 10.12万 - 项目类别:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
使用独特的纳米技术平台发现阿尔茨海默病药物
- 批准号:
8548221 - 财政年份:2012
- 资助金额:
$ 10.12万 - 项目类别:
Alzheimer's Drug Discovery Using Unique Nanotechnology Platform
使用独特的纳米技术平台发现阿尔茨海默病药物
- 批准号:
8446087 - 财政年份:2012
- 资助金额:
$ 10.12万 - 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
- 批准号:
7615522 - 财政年份:2007
- 资助金额:
$ 10.12万 - 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
- 批准号:
7184209 - 财政年份:2007
- 资助金额:
$ 10.12万 - 项目类别:
ADDLs, synapses & the molecular etiology of Alzheimer's disease
ADDL、突触
- 批准号:
7470605 - 财政年份:2007
- 资助金额:
$ 10.12万 - 项目类别:
Abeta oligomers (ADDLs) in Alzheimers Disease pathology
阿尔茨海默病病理学中的 Abeta 寡聚物 (ADDL)
- 批准号:
6678227 - 财政年份:2003
- 资助金额:
$ 10.12万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 10.12万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 10.12万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 10.12万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 10.12万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 10.12万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 10.12万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 10.12万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 10.12万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 10.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 10.12万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




